These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26657222)

  • 1. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
    Bender HS; Marshall Graves JA; Deakin JE
    Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.
    Pye R; Patchett A; McLennan E; Thomson R; Carver S; Fox S; Pemberton D; Kreiss A; Baz Morelli A; Silva A; Pearse MJ; Corcoran LM; Belov K; Hogg CJ; Woods GM; Lyons AB
    Front Immunol; 2018; 9():259. PubMed ID: 29515577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
    Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
    Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
    Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Flies AS; Lyons AB; Woods GM
    Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.
    Tovar C; Pye RJ; Kreiss A; Cheng Y; Brown GK; Darby J; Malley RC; Siddle HV; Skjødt K; Kaufman J; Silva A; Baz Morelli A; Papenfuss AT; Corcoran LM; Murphy JM; Pearse MJ; Belov K; Lyons AB; Woods GM
    Sci Rep; 2017 Mar; 7():43827. PubMed ID: 28276463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil.
    Hollings T; Jones M; Mooney N; McCallum H
    Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
    Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.
    Woods GM; Howson LJ; Brown GK; Tovar C; Kreiss A; Corcoran LM; Lyons AB
    J Immunol; 2015 Jul; 195(1):23-9. PubMed ID: 26092814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
    Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
    Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cellular immune responses of healthy and diseased Tasmanian devils (Sarcophilus harrisii).
    Kreiss A; Fox N; Bergfeld J; Quinn SJ; Pyecroft S; Woods GM
    Dev Comp Immunol; 2008; 32(5):544-53. PubMed ID: 17988737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
    Peel E; Belov K
    Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils.
    Deakin JE; Belov K
    Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathology of devil facial tumor disease (DFTD) in Tasmanian Devils (Sarcophilus harrisii).
    Loh R; Bergfeld J; Hayes D; O'hara A; Pyecroft S; Raidal S; Sharpe R
    Vet Pathol; 2006 Nov; 43(6):890-5. PubMed ID: 17099145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
    Phalen DN; Frimberger AE; Peck S; Pyecroft S; Harmsen C; Lola S; Moore AS
    Vet J; 2015 Dec; 206(3):312-6. PubMed ID: 26538144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Coorens THH; Darby J; Wilson R; McKay MJ; Kamath KS; Rubin A; Wakefield M; Mcintosh L; Mangiola S; Pye RJ; Flies AS; Corcoran LM; Lyons AB; Woods GM; Murchison EP; Papenfuss AT; Tovar C
    Cell Mol Life Sci; 2020 May; 77(9):1847-1858. PubMed ID: 31375869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii).
    Loh R; Hayes D; Mahjoor A; O'Hara A; Pyecroft S; Raidal S
    Vet Pathol; 2006 Nov; 43(6):896-903. PubMed ID: 17099146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.